Information regarding the pricing of Zepbound is not available in the provided text.
How is Zepbound administered?
Zepbound is administered as a subcutaneous injection [1].
What is Zepbound used for?
Zepbound (tirzepatide) is indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity [1]. It is used as an adjunct to a reduced-calorie diet and increased physical activity [1].
What is the active ingredient in Zepbound?
The active ingredient in Zepbound is tirzepatide [1]. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [1].
How does tirzepatide work for weight loss?
Tirzepatide, the active ingredient in Zepbound, activates both the GIP and GLP-1 receptors [1]. This dual action helps to regulate appetite and food intake [1].
What are the clinical trial results for Zepbound?
In clinical trials, tirzepatide led to significant reductions in body weight [1]. For instance, in one study, participants treated with tirzepatide achieved an average weight reduction of up to 22.5% after 72 weeks [1].
Are there any other drugs that contain tirzepatide?
Yes, tirzepatide is also the active ingredient in Mounjaro, which is indicated for the treatment of type 2 diabetes [2].
What is the difference between Zepbound and Mounjaro?
While both Zepbound and Mounjaro contain tirzepatide, they are indicated for different conditions. Zepbound is approved for chronic weight management, whereas Mounjaro is approved for improving glycemic control in adults with type 2 diabetes [1][2].
Where can I find more information on tirzepatide patents?
Information on patents related to tirzepatide can be found on DrugPatentWatch.com [3].
---
Sources:
1. Lilly. (n.d.). ZEPBOUND™ (tirzepatide) injection. Retrieved from https://www.zepbound.lilly.com/
2. Lilly. (n.d.). About Mounjaro. Retrieved from https://www.mounjaro.com/
3. DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/